SCHEMBL7735396

SCHEMBL7735396

NS(=O)(=O)c1cccc2c(O)nccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.62
LDHA P00338 1/20 0.53
FTO Q9C0B1 1/20 0.53
CA2 P00918 5/20 0.50
CA1 P00915 4/20 0.50
CA9 Q16790 3/20 0.50
MAPK1 P28482 1/20 0.45
MCL1 Q07820 2/20 0.41
CYP2C9 P11712 2/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
DNMT1 P26358 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
STAT3 P40763 1/20 0.40
TTR P02766 1/20 0.40
PNMT P11086 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5004409 0.84 TTR (0.53) CDK2FTOMCL1HSD17B10L3MBTL1
SCHEMBL21903885 0.83 CDK2 (0.41) CDK2LDHAFTOMCL1HSD17B10
SCHEMBL6994641 0.79 CDK2 (0.53) CDK2LDHAFTOCA2CA1
SCHEMBL9138970 0.79 CDK2 (0.78) CDK2LDHAFTOCA2CA1
SCHEMBL29401806 0.77 CDK2 (1.00) CDK2LDHAFTOCA2CA1
SCHEMBL588923 0.77 CDK2 (1.00) CDK2LDHAFTOCA2CA1
SCHEMBL7312121 0.76 CDK2 (0.50) CDK2LDHAFTOCA2CA1
SCHEMBL2907363 0.76 CYP3A4 (0.60) MAPK1CYP2C9HSD17B10TDP1MEN1
SCHEMBL30013323 0.76 CA1 (0.56) CDK2LDHAFTOCA2CA1
SCHEMBL30727430 0.76 CA2 (0.59) CDK2LDHAFTOCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403590-B1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia ALCON LABORATORIES, INC. 2002-06-11 US disclosed